You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

Displaying 1 - 10 of 12901 results
  1. A2A Adenosine Receptor Agonist for the Treatment of IBD

    SBC: ADENOSINE THERAPEUTICS, LLC            Topic: N/A

    DESCRIPTION (provided by applicant): Adenosine Therapeutics, LLC (ATL) is a biotechnology company started in Charlottesville, Virginia in 1999. ATL owns patents on the formulation and use of a family of potent and highly selective agonists of A2A adenosin

    SBIR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health
  2. AAAPT Technology for Improving Chemotherapy

    SBC: SCI-ENGI-MEDCO SOLUTIONS, INC            Topic: NCI

    DESCRIPTION provided by applicant Dysregulation of apoptosis pathways and loss of Human Beta Defensin hBD are the common tactics adapted by cancer cells to circumvent the effects of chemotherapy Consequently high dose of chemotherapy is required to obtain a clinically relevant therapeutic index which in turn compromises safety and develops resistance to therapy The problem is acute p ...

    SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  3. A1 adenosine agonist: antinociceptive effects

    SBC: Inotek Pharmaceuticals Corporation            Topic: N/A

    DESCRIPTION (provided by applicant): The current Phase I SBIR Grant application by Inotek Pharmaceuticals Corporation proposes to test the antinociceptive effect of a novel A1 receptor agonist in rat models. As preliminary data we present evidence in

    SBIR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health
  4. 2-5A Antisense for Degradation of SARS Coronavirus RNA

    SBC: RIDGEWAY BIOSYSTEMS, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Severe acute respiratory syndrome (SARS) is a newly recognized illness that has rapidly spread throughout Asia, North America and Europe. SARS has been found to be a highly infectious disease with high mortality,

    SBIR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health
  5. AAV2-ASPA-Based Metabolic Intervention for Alzheimer's Disease

    SBC: ASKLEPIOS BIOPHARMACEUTICAL, INC.            Topic: NIA

    Abstract We propose to initiate preclinical development of a gene therapeutic targeted to Alzheimer's Disease. The World Health Organization's and Alzheimer's Disease International's report on Dementia (2012) recognizes that the global burden of AlzheimerDisease is forecast to worsen significantly with prevalence predicted to double every 20 years. Interventions that could prov ...

    STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  6. Ab Alphavirus Replicon Vaccine against Cytomegalovirus

    SBC: GREER LABORATORIES, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): The objectives of the proposed research are to develop further an alphavirus replicon particle vaccine against human cytomegalovirus (CMV). CMV causes a chronic, persistent infection and is an important cause of morbi

    SBIR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health
  7. Abatement of Nitrous Oxide Emissions by Low Temperature Catalytic Decomposition

    SBC: SIENNA TECHNOLOGIES, INC.            Topic: 45

    75602-Nitric acid production is currently the largest source of nitrous oxide emissions in the chemical industry. Reductions in these emissions are urgently required because nitrous oxide is both a strong greenhouse gas and an ozone layer depleter. Although measures exist to eliminate nitrous oxide emissions from adipic acid plants, they cannot be applied to eliminate nitrous oxide emissions fro ...

    SBIR Phase I 2004 Department of Energy
  8. ABEL: an Adaptive Belief Engine for Satellite Cluster Data Fusion

    SBC: INTERFACE & CONTROL SYSTEMS, INC.            Topic: AF02062

    Data Fusion has emerged as a critical technology to be developed and deployed for military projects encompassing Space Situational Awareness, and Offensive/Defensive Counterspace to increase the warfighter's ability to identify, characterize, geo-locate and assess attacks. Fusion has also been identified as a major risk to be mitigated for the NASA/Air Force Joint Space Launch Initiative (SLI) Re ...

    SBIR Phase II 2004 Department of DefenseAir Force
  9. Aberration-Corrected Retinal Spot Projector and Imager (ARSPI)

    SBC: AGILOPTICS            Topic: AF04073

    Intellite, Incorporated will team with the Optical Sciences Center at the University of Arizona to develop an adaptive optics system that will project a diffraction-limited spot on the retina by pre-correcting the laser beam for all significant optical aberrations of the specific eyeball under test. The system will use real-time feedback from a low-power laser reflected from the retina to measure ...

    SBIR Phase I 2004 Department of DefenseAir Force
  10. A Bioactive Nanofibrous Sewing Cuff for Treatment of Cardiac Valvular Disease

    SBC: BIOSURFACES INC            Topic: NHLBI

    PROJECT SUMMARY Cardiac valve repair or replacement is indicated when progression of degenerative disease or bacterial infection of the native valve results in valvular dysfunction, thereby impacting cardiac output. Both procedures require the use of a woven or knitted polyester material with an internal reinforcement (Teflon, silicone or metal) to either stabilize the native valve (annuloplasty r ...

    SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government